| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851687 | American Heart Journal | 2006 | 7 Pages |
Abstract
The FAVORIT trial is designed with sufficient power and follow-up time to detect a clinically relevant change in CVD risk between renal transplant recipients receiving a high or low tHcy-lowering folic acid multivitamin. Preliminary screening and baseline data support the trial's objectives.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew G. MD, MS, Myra A. PhD, John W. PhD, Lawrence G. MD, Marc A. MD, PhD, Andrew S. MD, Paul F. ScD, Joyce MA, MPH, for the FAVORIT Investigators for the FAVORIT Investigators,